Differential effects of anaemia and iron deficiency on long-term outcomes following transcatheter edge-to-edge repair in degenerative vs. secondary mitral regurgitation: results from a large single-center study
Authors:
- Schajesta KhurramiSKSchajesta Khurrami
- Benedikt KöllBKBenedikt Köll
- Sebastian LudwigSLSebastian Ludwig
- Christoph PauschingerCPChristoph Pauschinger
- Jessica WeimannJWJessica Weimann
- Hermann ReichenspurnerHRHermann Reichenspurner
- Lenard ConradiLCLenard Conradi
- Andreas SchaeferASAndreas Schaefer
- Stefan BlankenbergSBStefan Blankenberg
- Edith LubosELEdith Lubos
- Niklas SchoferNSNiklas Schofer
- Daniel KalbacherDKDaniel Kalbacher
- 2 May 2023
- journal article
- research article
- Published by Springer Nature in Clinical Research in Cardiology
- Vol. 112 (7) , 967-980
Abstract
Background Anaemia and iron deficiency (ID) are independently associated with adverse outcomes in patients with cardiovascular diseases, especially in those with heart failure. Here, we aimed to clarify the long-term effect of anaemia and ID on outcomes in patients undergoing transcatheter mitral edge-to-edge repair (TEER) for relevant mitral regurgitation (MR) as well as to relate these to the underlying MR aetiology. Methods 833 patients (median age 77.1 years, 40.7% women, 63.3% secondary MR) treated by TEER between 09/2008 and 07/2019 were included and stratified according to baseline anaemia (hemoglobin < 12 g/dL in women and < 13 g/dL in men) or ID. Results Anaemia and ID were frequent with 61.6% and 68.1%, respectively. Anaemic patients had a lower functional status at baseline and were less likely to improve after TEER. In addition, anaemia was associated with all-cause mortality (hazard ratio [HR] = 1.68, 95% confidence interval [CI] 1.36–2.07, p < 0.001) and the composite endpoint of death or heart failure (HF) rehospitalization (HR = 1.30, 95% CI 1.10–1.54, p = 0.002). In contrast, ID was not associated with either all-cause mortality or the composite endpoint of death or HF rehospitalization. Conclusion Patients undergoing TEER have high rates of both anaemia and ID. However, anaemia is associated with worse functional baseline status and post-interventional improvements compared to ID. Furthermore, anaemia is linked to higher rates of mortality and HF rehospitalization, particularly in those with secondary MR.Keywords
This publication has 24 references indexed in Scilit:
- Restrictive or Liberal Red-Cell Transfusion for Cardiac SurgeryNew England Journal of Medicine, 2017
- Functional status and quality of life after transcatheter mitral valve repair: a prospective cohort study and systematic reviewClinical Research in Cardiology, 2017
- Prevalence and Outcomes of Anemia and Hematinic Deficiencies in Patients With Chronic Heart FailureJAMA Cardiology, 2016
- Percutaneous mitral valve repair using the MitraClip® system in patients with anemiaInternational Journal of Cardiology, 2015
- Percutaneous Mitral Valve Repair for Mitral Regurgitation in High-Risk PatientsJACC, 2014
- The Independent Effects of Anemia and Transfusion on Mortality After Coronary Artery BypassThe Annals of Thoracic Surgery, 2014
- Iron deficiency in chronic heart failure: An international pooled analysisAmerican Heart Journal, 2013
- Anaemia is an independent predictor of death in patients hospitalized for acute heart failureClinical Research in Cardiology, 2009
- Quantitative Assessment of Severity of Mitral Regurgitation by Serial Echocardiography in a Multicenter Clinical Trial of Percutaneous Mitral Valve RepairThe American Journal of Cardiology, 2007
- Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and doppler echocardiographyJournal of the American Society of Echocardiography, 2003